1977
|
DMOG
|
Cell-permeable HIF-PHD inhibitor with pro-angiogenic and -osteogenic properties |
€65.00 |
2384
|
FDI 6
|
Inhibitor of the Forkhead box protein M1 (FOXM1) |
€99.00 |
2331
|
FRAX 486
|
Bioavailable, brain penetrating inhibitor of p21-activated kinases (PAKs) |
€90.00 |
2410
|
GSK 5959
|
Potent, cell permeable inhibitor of BRPF1 bromodomain |
€135.00 |
1742
|
NS 30678 hydrochloride
|
D2 ligand with surmountable/competitive-like D2 antagonist properties |
€115.00 |
1332
|
NSC 45913
|
Building Block; unknown pharmacology |
Inquire |
2393
|
NSC 756093
|
Potent in vitro inhibitor of GBP1:PIM1 interaction |
€125.00 |
1944
|
NVP-BGJ398 phosphate
|
Inhibitor of FGFR tyrosine kinases 1, 2 ,3 and 4 |
€90.00 |
2328
|
PTIQ
|
Neuroprotectant with attenuating effects on MMP-3 expression |
€125.00 |
2303
|
R 55
|
Retromer stabilizing pharmacological chaperone. Potential Alzheimer's therapeutic |
€95.00 |
2324
|
SC 144 hydrochloride
|
The first-in-class small-molecule gp130 inhibitor |
€130.00 |
2398
|
Suprafenacine
|
Destabilizer of microtubules that causes cell cycle arrest in the G2/M phase |
€110.00 |
1987
|
XE 991
|
KCNQ channel and M-current blocker |
€90.00 |